Activity of Decitabine (DAC) combined with All-Trans Retinoic Acid (ATRA) in oligoblastic AML: Results from a randomized 2x2 phase II trial (DECIDER)
C. Rummelt,O. Grishina,C. Schmoor,M. Crysandt, E. Jost, F. Thol,M. Heuser, K. S. Goetze,H. R. Salih, K. Doehner,H. R. Salih, M. M. Schittenhelm,G. Heil, C. Schwaenen, C. Mueller-Tidow,W. Brugger, A. Kuendgen, U. Germing, M. de Witt, S. Kremers,A. Giagounidis,S. Scholl,A. Neubauer,J. Krauter,G. Bug, R. Waesch,H. Becker,A. M. May,J. Duyster,A. Ganser, H. Doehner,B. Hackanson,M. Luebbert ONCOLOGY RESEARCH AND TREATMENT（2021）
AI 理解论文
溯源树
样例
